Dmard

News

November 06, 2024

2 min read

Save

Older, Asian patients less likely to receive b/ts DMARDs for rheumatoid arthritis

Older, Asian patients less likely to receive b/ts DMARDs for rheumatoid arthritis

Patients with rheumatoid arthritis aged younger than 40 years are more than twice as likely to receive biologic or targeted synthetic disease-modifying anti-rheumatic drugs vs. older individuals, according to data.

Clinical Guidance

Psoriasis

Treatment Options

Oral Systemic Therapy for Psoriasis

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Rheumatoid Arthritis

Treatment Options

Conventional Synthetic Disease-Modifying Antirheumatic Drugs

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Rheumatoid Arthritis

Treatment Options

Corticosteroid Therapy

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Rheumatoid Arthritis

Treatment Guidelines

Pharmacotherapy and Management Guidelines

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Rheumatoid Arthritis

Presentation and Diagnosis

Diagnosis of Early Rheumatoid Arthritis

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Ankylosing Spondylitis

Assessment and Treatment

Assessment and Monitoring

Muhammad Asim Kahn, MD, FRCP, MACP; Nurullah Akkoç, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Ankylosing Spondylitis

Presentation and Diagnosis

Impact of COVID-19 Pandemic on the Care of Patients With axSpA

Muhammad Asim Kahn, MD, FRCP, MACP; Nurullah Akkoç, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News

June 27, 2024

2 min read

Save

Upadacitinib’s risk-benefit profile in rheumatoid arthritis ‘favorable’ through 5 years

The risk-benefit profile of upadacitinib for rheumatoid arthritis “remains favorable” through 5 years, according to data published in The Journal of Rheumatology.

News

June 26, 2024

2 min read

Save

Bimekizumab results in rapid, sustained improvements to PsA patient reported outcomes

Bimekizumab results in rapid, sustained improvements to PsA patient reported outcomes

Bimekizumab treatment for psoriatic arthritis demonstrated rapid, clinically meaningful improvements to patient reported outcomes that were sustained up to 1 year, according to data published in Rheumatology.